Atom | Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed)

Due Dates: July 13, 2025 (Letter of Intent/Earliest Submission) | August 13, 2025 (Application Due)

Funding Amounts: ~$2,000,000 total in FY 2026 for 3–4 awards; no budget cap, up to 5 years/project.

Summary: Supports research using ex vivo human iPSC-derived models to study neuroimmune and neuronal-glial mechanisms linking HIV-associated neurological disorders and addictive substance use.

Key Information: Clinical trials are not allowed; applications must use human cells/tissues and address addictive substances (not alcohol only).

Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed)

Sign in to see full grant listing